A Phase 1, Randomized,Open-Label,Safety, Tolerability,and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate,and Intranasal DHE Mesylate Spray in Healthy Adult Subjects |
| |
| Authors: | Detlef Albrecht MD Mic Iwashima Debbie Dillon Stuart Harris MD Jeff Levy MD |
| |
| Affiliation: | 1. Satsuma Pharmaceuticals Inc., South San Francisco, CA, USA;2. Seaview/Quotient, Miami, FL, USA |
| |
| Abstract: | |
| |
| Keywords: | dihydroergotamine mesylate dihydroergotamine migraine pharmacokinetics intranasal |
|
|
